July 18, 2000IBU Brand Ibuprofen Tablets
LA (SafetyAlerts) - The Food and
Drug Administration (FDA) today reported that BASF Corporation is conducting a recall of
certain IBU (Ibuprofen) Tablets because the product exceeds impurity specification at
18-month stability (4-isobutylacetophenone).
IBU Tablets (Ibuprofen), 800 mg, in 500-count bottles, Rx non-steroidal anti-inflammatory
Par NDC #49884-469-05. Recall #D-429-0. Class III
Lot #20692 EXP 11/00.
BASF Corporation, Shreveport, Louisiana.
Manufacturer, by telephone on May 19, 2000. Firm-initiated recall ongoing. This is
the first public notice issued by the FDA.
9,279 bottles were distributed.
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA.
Notice of this product warning was sent via email
to SafeMail subscribers July 18,
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.